Vitamin D and cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in end-stage renal disease (ESRD) patients.
• Vitamin D deficiency is highly prevalent in individuals with declining kidney function.
• Active vitamin D supplementation has demonstrated improved survival rates in dialysis patients.

Purpose of the Study:

• To explore the intricate relationship between vitamin D and cardiovascular disease (CVD) in end-stage renal disease (ESRD).
• To investigate the role of genetic factors in the co-occurrence of vitamin D deficiency and CVD.
• To understand vitamin D's influence on the pathogenesis of cardiovascular complications.

Main Methods:

• Literature review of studies investigating vitamin D, ESRD, and CVD.
• Analysis of genetic associations between vitamin D deficiency and cardiovascular risk.
• Examination of vitamin D receptor expression in cardiac tissue.

Main Results:

• Vitamin D deficiency is a common comorbidity in ESRD patients.
• Evidence suggests a significant association between vitamin D status and cardiovascular outcomes in ESRD.
• Vitamin D receptor presence in the heart muscle indicates a direct role in cardiac function.
• Genetic predispositions can contribute to both vitamin D deficiency and CVD.

Conclusions:

• Vitamin D plays a crucial role in modulating cardiovascular disease (CVD) in patients with end-stage renal disease (ESRD).
• Targeting vitamin D deficiency may be a viable strategy to improve cardiovascular outcomes in this vulnerable population.